D-0187-2016 Class II Terminated

Recalled by The Compounder — Aurora, IL

FDA drug recall D-0187-2016 was initiated by The Compounder on Mar 10, 2015 and is designated Class II. Reason for recall: Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination. The recall status is terminated (terminated May 19, 2016). Affected quantity: 3 (10mL) syringes.

Recall Details

Product Type
Drugs
Report Date
Nov 18, 2015
Initiation Date
Mar 10, 2015
Termination Date
May 19, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3 (10mL) syringes

Product Description

BIEST TD 50/50 (Estradiol USP Micronized (E2)/Estriol USP Micronized (E3)) W/V (weight /volume) 2.5 MG/ML transdermal cream, dispensed in 10 mL prefilled syringes, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.

Reason for Recall

Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.

Distribution Pattern

Nationwide

Code Information

Lot # 01232015:03@14, Exp 4/23/2015

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0187-2016
openFDA file date
Oct 27, 2026
Loaded by RegDataLab
Oct 29, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.